Related Experiment Video
Updated: Aug 19, 2025
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
eHealth in TB clinical management.
I Margineanu1, C Louka2, O Akkerman3
1Department of Clinical Pharmacy and Pharmacology, University Medical Centrum Groningen, University of Groningen, Groningen, the Netherlands, Iasi Pulmonary Diseases University Hospital, Iasi, Romania.
Summary
eHealth, the digital delivery of healthcare services, shows promise in improving tuberculosis (TB) clinical management. While cost-effective and user-accepted, challenges like hardware and software issues need addressing for wider adoption.
Area of Science:
- Digital Health
- Public Health
- Infectious Disease Management
Background:
- The proliferation of internet and mobile technologies has spurred the growth of eHealth, offering new avenues for healthcare delivery.
- eHealth applications are increasingly being explored for their potential to transform healthcare services.
Purpose of the Study:
- To conduct a meta-analysis examining the impact of eHealth on tuberculosis (TB) clinical management.
- To identify benefits and challenges of eHealth interventions in TB care.
- To formulate recommendations for the future development of eHealth in TB management.
Main Methods:
- A systematic literature search was conducted using PRISMA guidelines across PubMed and Embase up to April 2021.
- Included studies evaluated internet and/or mobile-based eHealth interventions impacting TB clinical management.
- Outcomes were assessed based on the WHO "Recommendations on Digital Interventions for Health System Strengthening" framework.
Main Results:
- Of 3,873 initial studies, 89 were included in the final analysis.
- eHealth interventions demonstrated positive effects on TB screening, diagnosis, and treatment indicators.
- Interventions were found to be cost-effective and well-accepted by users, though hardware malfunctions and software misuse were noted challenges.
Conclusions:
- eHealth applications present a significant opportunity to enhance the clinical management of tuberculosis.
- Consistent benefits were reported across studies, alongside specific implementation challenges.
- Further research and development in eHealth are recommended to optimize TB care delivery.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
01:26Pulmonary Tuberculosis IV
186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
01:29Pulmonary Tuberculosis I
297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
01:31Pulmonary Tuberculosis III
411
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
411
01:28Pulmonary Tuberculosis II
299
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
299
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K